Category: Medical
-

STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-

STAT+: New rule would force PBMs to disclose drug rebates and other fees
•
Pharmacy benefit managers face new, sweeping requirements to disclose all the different ways they get money from providing…
-

STAT+: AstraZeneca looks to China for obesity drug candidates
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about TrumpRx questions, drugmakers lowering some prices, and more
•
And so, another working week will soon come to an end. This is, you may recall, our treasured…
-

STAT+: States are the next vaccine battleground
•
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health…
-

STAT+: Oz, other officials meet with key senators to push Trump’s ideas for lower drug prices
•
WASHINGTON — Top Trump administration officials met with Republican lawmakers on the Senate Finance Committee Wednesday to push…
-

STAT+: Lilly, Repertoire strike $2 billion autoimmune alliance
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about AstraZeneca investing in China, an abandoned overdose antidote, and more
•
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
-

STAT+: How Opvee, Indivior’s powerful overdose antidote, went bust
•
It was cast as a lifesaving medication, a “best-in-class” overdose antidote built specifically for the fentanyl era. It…
-

STAT+: Eli Lilly expands work on gene therapies for hearing
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about Medicare drug prices, the EU-India trade deal, and more
•
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and…
-

STAT+: More high-income countries have used compulsory licenses to gain access to meds, study finds
•
The use of compulsory licenses by high-income countries to gain access to medicines increased considerably over a recent…
-

STAT+: Startup Altido Bio pursues CAR-T for glioblastoma tumors
•
Nick Leschly, the CEO who became synonymous with the curative promise and complicated reality of gene therapy, is…
-

STAT+: New startup to develop a GLP-1 drug for addiction
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about a Roche obesity drug, a clash over 340B claims data, and more
•
Hello, everyone, and how are you today? We are just fine, thank you, despite the frigid temperature and…
-

STAT+: Roche moves obesity drug to pivotal trials after mid-stage success
•
Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after reporting Tuesday that…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement




